News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Molecular Diagnostics Industry Executive, Dr. Heiner Dreismann, Joins ChondroGene Inc. (CDG.V)'s Board



9/19/2006 10:04:17 AM

TORONTO, Sept. 19 /PRNewswire-FirstCall/ - ChondroGene Limited (TSX Venture: CDG - News) announced today that former Roche Molecular Systems CEO, Dr. Heiner Dreismann, PhD, has joined ChondroGene's Board of Directors. Dr. Dreismann is a veteran of the molecular diagnostics industry who will bring a wealth of experience, contacts and insight to ChondroGene as it moves into the commercialization of its blood-based molecular diagnostic tests.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES